Teb Dergi Temmuz 2009 SON.FH10
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Ep 1384475 A1
Europäisches Patentamt *EP001384475A1* (19) European Patent Office Office européen des brevets (11) EP 1 384 475 A1 (12) EUROPEAN PATENT APPLICATION published in accordance with Art. 158(3) EPC (43) Date of publication: (51) Int Cl.7: A61K 31/352, C07D 311/76, 28.01.2004 Bulletin 2004/05 A61P 1/16, A23L 1/30, A23K 1/16 (21) Application number: 02713236.4 (86) International application number: (22) Date of filing: 28.03.2002 PCT/JP2002/003098 (87) International publication number: WO 2002/080904 (17.10.2002 Gazette 2002/42) (84) Designated Contracting States: • KAYAHASHI, Shun, AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU Tsukuba Research Laboratories MC NL PT SE TR Tsukuba-shi, Ibaraki 305-0841 (JP) Designated Extension States: • HASHIZUME, Erika, AL LT LV MK RO SI Tsukuba Research Laboratories Tsukuba-shi, Ibaraki 305-0841 (JP) (30) Priority: 05.04.2001 JP 2001106600 • NAKAGIRI, Ryusuke, Tsukuba Research Laboratories (71) Applicant: KYOWA HAKKO KOGYO CO., LTD. Tsukuba-shi, Ibaraki 305-0841 (JP) Chiyoda-ku, Tokyo 100-8185 (JP) (74) Representative: Casalonga, Axel et al (72) Inventors: BUREAU D.A. CASALONGA - JOSSE • SAKAI, Yasushi, Paul-Heyse-Strasse 33 Foods & Liquors Research Laborat. 80336 München (DE) Inashiki-gun, Ibaraki 300-0398 (JP) (54) LIVER FUNCION PROTECTING OR AMELIORATING AGENT (57) A liver function protecting or improving agent which comprises a compound represented by the formula (I) {in the formula (I), R1,R2,R3,R4,R5,R6,R7,R8and R9 may be the same or different, and represent hydrogen, halogen, hydroxy, alkoxy or alkyl; and RA represents the formula (II) EP 1 384 475 A1 Printed by Jouve, 75001 PARIS (FR) (Cont. -
Vasorelaxant Effects of Methanolic Extract and Principal Constituents of Sweet Hydrangea Leaf on Isolated Rat Aorta
Journal of the Academic Society for Quality of Life (JAS4QoL) 2018 Vol. 4(1) 2:1-6 Vasorelaxant Effects of Methanolic Extract and Principal Constituents of Sweet Hydrangea Leaf on Isolated Rat Aorta Souichi NAKASHIMA, Seikou NAKAMURA, Takuya IWAMOTO, Yui MASUKAWA, Yuika EMI, Ayako OHTA, Nami NOMURA, Hisashi MATSUDA* Kyoto Pharmaceutical University; Misasagi, Yamashina-ku, Kyoto 607–8 !", #apan. &itation: NAKASHIMA, S.; NAKAMURA, S.; IWAMOTO, T.; MASUKAWA, Y.; EMI, Y.; OHTA, A.; NOMURA, N.; MATSUDA, H. (asorelaxant Effects o, Methanolic *)tract an- Princi$al &onstituents o, ./eet Hy-rangea Leaf on Isolate- Rat Aorta JAS4QoL 2018, 4(1) 2'!-6% 5nline' h6$'77as48ol.org/9$:"08 ;art! 3eceive- Date' "0!870=7"> Acce$te- Date' "0!870=7"6 Pu?lishe-' "0!870 70! 2018 International Conference and Cruise • @e "0!8 2nternational &onference on Aality o, 1i,e /ill ?e a 5-night Genting Dream Cruise leaving Sunday, Sept. 2nd, 2018 ,rom .ingapore, visiting Malaysia, &am?o-ia, 1aem &habang in @ailand, and returning to Singapore on !riday, Sept. 6th, 2018% • Be are no/ calling ,or $apers% Procee-ings as /ell as $hotos and other information ,rom $ast con- ,erences can be found at h6$'77as48ol.org/ic8ol/"0!87 By special arrangement with the cruise operators, Conference attendees will receive a one-time special discount. Full details to be as4qol.org icqol !"#$ accomodations . % 4uthor for correspon-ence (matsu-aDmb%kyoto-$hu%ac%E$F #asorelaxant %ffects of Methanolic %xtract and (rincipal Constituents of S)eet Hydrangea Leaf on Isolated Rat Aorta Souichi NAKASHIMA, Seikou NAKAMURA, Takuya IWAMOTO, Yui MA- SUKAWA, Yuika EMI, Ayako OHTA, Nami NOMURA, and Hisashi MATSUDA* Kyoto Pharmaceutical University; Misasagi, Yamashina-ku, Kyoto 607–8 !", #apan. -
Differentiation Inducing Activities of Isocoumarins from Hydrangea Dulcis Folium
566 Notes Chem. Pharm. Bull. 48(4) 566—567 (2000) Vol. 48, No. 4 Differentiation Inducing Activities of Isocoumarins from Hydrangea Dulcis Folium Kaoru UMEHARA,* Misae MATSUMOTO, Mitsuhiro NAKAMURA, Toshio MIYASE, Masanori KUROYANAGI, and Hiroshi NOGUCHI School of Pharmaceutical Sciences, University of Shizuoka, 52–1 Yada, Shizuoka 422–8526, Japan. Received September 13, 1999; accepted December 20, 1999 In the course of searching for differentiation inducers against leukemic cells from plants, we have recognized the differentiation inducing activities of the methanolic extract of Hydrangea Dulcis Folium. Activity guided sep- aration of the extract was carried out using M1 cells, and seven isocoumarins were isolated as active substances. These isocoumarins showed the activities at the concentration of 100 mM and non-cytotoxic effects even at 300 mM. Key words differentiation; Hydrangea Dulcis Folium; M1 cell; phagocytosis Differentiation inducers are of potential interest for the shown). They showed hardly any antiproliferative activities, treatment of human cancers promoting the terminal differen- and a more than 70% of growth ratio was found in 300 m M of tiation of certain human tumor cells. We have reported the these compound treated groups. Glucosides were good pro- differentiation inducing activities of triterpenes, flavones, lig- inducers. nans, and steroids.1) These compounds differentiated mouse Isocoumarins (6—8) were recongnized to have higher ac- myeloid leukemia (M1) cells into phagocytic cells, and some tivities than dihydroisocoumarins (1—5). Phagocytic activi- of them also induced the differentiation of human acute ties were observed when M1 cells were treated with 100 m M promyelocytic leukemia (HL-60) cells. In the course of of isocoumarins (6—8) and the activities were nearly equal searching for differentiation inducers against leukemic cells, to 300 m M treated groups of dihydroisocoumarins (1—5). -
Isocoumarins and 3,4-Dihydroisocoumarins, Amazing Natural Products: a Review
Turkish Journal of Chemistry Turk J Chem (2017) 41: 153 { 178 http://journals.tubitak.gov.tr/chem/ ⃝c TUB¨ ITAK_ Review Article doi:10.3906/kim-1604-66 Isocoumarins and 3,4-dihydroisocoumarins, amazing natural products: a review Aisha SADDIQA1;∗, Muhammad USMAN2, Osman C¸AKMAK3 1Department of Chemistry, Faculty of Natural Sciences, Government College Women University, Sialkot, Pakistan 2Department of Chemistry, Government College of Science, Lahore, Pakistan 3Department of Nutrition and Dietetics, School of Health Sciences, Istanbul_ Geli¸simUniversity, Avcılar, Istanbul,_ Turkey Received: 23.04.2016 • Accepted/Published Online: 10.09.2016 • Final Version: 19.04.2017 Abstract: The isocoumarins are naturally occurring lactones that constitute an important class of natural products exhibiting an array of biological activities. A wide variety of these lactones have been isolated from natural sources and, due to their remarkable bioactivities and structural diversity, great attention has been focused on their synthesis. This review article focuses on their structural diversity, biological applications, and commonly used synthetic modes. Key words: Isocoumarin, synthesis, natural product, biological importance 1. Introduction The coumarins 1 are naturally occurring compounds having a fused phenolactone skeleton. Coumarin 1 was first extracted from Coumarouna odorata (tonka tree). 1 The isocoumarins 2 and 3,4-dihydroisocoumarins 3 are the isomers of coumarin 1. A number of substituted isocoumarins have been found to occur in nature; however, the unsubstituted isocoumarins have not been observed to occur naturally. Furthermore, sulfur, selenium, and tellurium analogues 4a{4c have also been known since early times (Figure 1). Figure 1. Some naturally occurring isocoumarins. The isocoumarins and their analogues occur in nature as secondary metabolites (i.e. -
(12) Patent Application Publication (10) Pub. No.: US 2008/0161324 A1 Johansen Et Al
US 2008O161324A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2008/0161324 A1 Johansen et al. (43) Pub. Date: Jul. 3, 2008 (54) COMPOSITIONS AND METHODS FOR Publication Classification TREATMENT OF VRAL DISEASES (51) Int. Cl. (76) Inventors: Lisa M. Johansen, Belmont, MA A63/495 (2006.01) (US); Christopher M. Owens, A63L/35 (2006.01) Cambridge, MA (US); Christina CI2O I/68 (2006.01) Mawhinney, Jamaica Plain, MA A63L/404 (2006.01) (US); Todd W. Chappell, Boston, A63L/35 (2006.01) MA (US); Alexander T. Brown, A63/4965 (2006.01) Watertown, MA (US); Michael G. A6II 3L/21 (2006.01) Frank, Boston, MA (US); Ralf A6IP3L/20 (2006.01) Altmeyer, Singapore (SG) (52) U.S. Cl. ........ 514/255.03: 514/647; 435/6: 514/415; Correspondence Address: 514/460, 514/275: 514/529 CLARK & ELBNG LLP 101 FEDERAL STREET BOSTON, MA 02110 (57) ABSTRACT (21) Appl. No.: 11/900,893 The present invention features compositions, methods, and kits useful in the treatment of viral diseases. In certain (22) Filed: Sep. 13, 2007 embodiments, the viral disease is caused by a single stranded RNA virus, a flaviviridae virus, or a hepatic virus. In particu Related U.S. Application Data lar embodiments, the viral disease is viral hepatitis (e.g., (60) Provisional application No. 60/844,463, filed on Sep. hepatitis A, hepatitis B, hepatitis C, hepatitis D, hepatitis E). 14, 2006, provisional application No. 60/874.061, Also featured are screening methods for identification of filed on Dec. 11, 2006. novel compounds that may be used to treat a viral disease. -
A New Total Synthesis of Natural Isocoumarin, Thunberginol B
General Papers ARKIVOC 2007 (xiv) 12-19 A new total synthesis of natural isocoumarin, thunberginol B Ghulam Qadeera, Nasim Hasan Ramaa, * and Syed Jabbar Hussain Shahb a Department of Chemistry, Quaid-I-Azam University, Islamabad 45320, Pakistan bInstitute of Organic Chemistry, Humbolt University, Brooke-taylor-strasse 2, 12489 Berlin, Germany E-mail: [email protected] Abstract 3,5-Dimethoxyhomophthalic acid is a key intermediate for the synthesis of highly biological active naturally and non-naturally occurring isocoumarins and 3,4-dihydroisocoumarins. It was synthesized efficiently in five steps from 3,5-dimethoxybenzaldehyde (1) via a series of reactions including synthesis of 3,5-dimethoxycinnamic acid (2) and 3-(3′,5′-dimethoxyphenyl)propionic acid (3), cyclization of 3-(3′,5′-dimethoxyphenyl)propionic acid (3) to 5,7-dimethoxy-1- indanone (4) and oxidative decomposition of methyl 2-hydroxy-2-(5,7-dimethyoxy-1-oxo-1H- inden-2(3H)-ylidene)acetate (5) to 3,5-dimethoxyhomophthalic acid (6). Natural isocoumarin, thunberginol B [3-(3′,4′-dihydroxyphenyl)-6,8-dihydroxyisocoumarin] (10) was synthesized by the condensation of 3,5-dimethoxyhomophthalic acid (6) with 3,4-dimethoxybenzoic acid (7) followed by demethylation of intermediate [3-(3′,4′-dimethoxyphenyl)-6,8- dimethoxyisocoumarin] (9). The synthesized compounds were purified by HPLC and characterized by elemental analysis, IR, 1H NMR and mass spectrometry. Keywords: 3,5-Dimethoxyhomophthalic acid, thunberginol B, synthesis, demethylation Introduction Isocoumarin structures are -
Biol. Pharm. Bull. 42(3): 424-431 (2019)
424 Biol. Pharm. Bull. 42, 424–431 (2019) Vol. 42, No. 3 Regular Article Chemical Constituents from Leaves of Hydrangea serrata and Their Anti-photoaging Effects on UVB-Irradiated Human Fibroblasts Ji-Sun Shin,a Hee-Soo Han,a,b Seung-Bin Lee,a,b Da-bin Myung,a,b Keunsuk Lee,c Sun Hee Lee,c Hyoung Ja Kim,*,d and Kyung-Tae Lee*,a,b a Department of Pharmaceutical Biochemistry, College of Pharmacy, Kyung Hee University; Seoul 02447, Republic of Korea: b Department of Life and Nanopharmaceutical Sciences, College of Pharmacy, Kyung Hee University; Seoul 02447, Republic of Korea: c Department of New Material Development, COSMAXBIO; Gyeonggi 13486, Republic of Korea: and d Molecular Recognition Research Center, Materials and Life Science Research Division, Korea Institute of Science and Technology; Seoul 02792, Republic of Korea. Received September 25, 2018; accepted November 28, 2018 Hydrangea serrata (THUNB.) SER. (Hydrangeaceae) leaves have been used as herbal teas in Korea and Japan. The objective of this study was to identify anti-photoaging compounds in aqueous EtOH extract pre- pared from leaves of H. serrata and their effects on UVB-irradiated Hs68 human foreskin fibroblasts. Phyto- chemical study on H. serrata leaves led to the isolation and characterization of ten compounds: hydrangenol, thunberginol A, thunberginol C, hydrangenoside A, hydrangenoside C, cudrabibenzyl A, 2,3,4-trihydroxys- tilbene, thunberginol F, quercetin 3-O-β-D-xylopyranosyl (1-2)-β-D-galactopyranoside, quercetin 3-O-β-D- xylopyranosyl (1-2)-β-D-glucopyranoside. Cudrabibenzyl A, 2,3,4-trihydroxystilbene, quercetin 3-O-β-D- xylopyranosyl (1-2)-β-D-galactopyranoside, quercetin 3-O-β-D-xylopyranosyl (1-2)-β-D-glucopyranoside were firstly isolated from H. -
Wo 2008/033466 A2
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date PCT (10) International Publication Number 20 March 2008 (20.03.2008) WO 2008/033466 A2 (51) International Patent Classification: [US/US]; 1750 Washington Street, Boston, MA 021 18 A61K 31/4704 (2006.01) (US). ALTMEYER, RaIf [DE/SG]; 19 Cairnhill Circle, Apartment 17-06, Singapore 229768 (SG). (21) International Application Number: PCT/US2007/019932 (74) Agent: BELLIVEAU, Michael, J.; Clark & Elbing LLP, 101 Federal Street, Boston, MA 021 10 (US). (22) International Filing Date: 13 September 2007 (13.09.2007) (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, (25) Filing Language: English AT,AU, AZ, BA, BB, BG, BH, BR, BW, BY,BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, (26) Publication Language: English ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, (30) Priority Data: LR, LS, LT, LU, LY,MA, MD, ME, MG, MK, MN, MW, 60/844,463 14 September 2006 (14.09.2006) US MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, 60/874,061 11 December 2006 (11.12.2006) US PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, (71) Applicant (for all designated States except US): COM- ZM, ZW BINATORX (SINGAPORE) PRE. -
Synthesis, Characterization and Biological Activities of Isocoumarins, Triazoles, Thiadiazoles and Indolinones
SYNTHESIS, CHARACTERIZATION AND BIOLOGICAL ACTIVITIES OF ISOCOUMARINS, TRIAZOLES, THIADIAZOLES AND INDOLINONES A DISSERTATION SUBMITTED TO THE QUAID-I-AZAM UNIVERSITY ISLAMABAD IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY IN ORGANIC CHEMISTRY BY GHULAM QADEER Department of Chemistry, Quaid-i-Azam University, Islamabad, Pakistan. 2008 SYNTHESIS, CHARACTERIZATION AND BIOLOGICAL ACTIVITIES OF ISOCOUMARINS, TRIAZOLES, THIADIAZOLES AND INDOLINONES BY GHULAM QADEER Department of Chemistry, Quaid-i-Azam University, Islamabad, Pakistan. 2008 Allah will exalt those who believe among you, and those who have knowledge to high ranks. Saying of Holy Prophet Hazrat Muhammad “Do you know who is the most beneficent? Allah is the most beneficent, than of the children of the man; I am the most beneficent and after me the most beneficent among them is the man who acquires knowledge and spreads it, he will come on the day of resurrection as a chief by himself”. My parents ACKNOWLEDGEMENT First of All I bow my head before “Almighty Allah” Who bestowed me the opportunity and potential to make material contribution to the already existing ocean of knowledge and all respects are for the Holy Prophet, Hazrat Muhammad who enabled us to recognize our Creator. It is a matter of great pleasure to express my obligations and sincere thanks to my teacher and research supervisor Prof. Dr. Nasim Hasan Rama, Department of Chemistry, Q. A. U. Islamabad, for his constant encouragement, keen interest and thought provoking guidance through out my research work. I am thankful to Prof. Dr S. Sakhawat shah, Chairman, Department of Chemistry, for providing necessary research facilities. -
Inhibitory Effects of Thunberginols A, B, and F on Degranulations and Releases of TNF-A and IL-4 in RBL-2H3 Cells
388 Notes Biol. Pharm. Bull. 30(2) 388—392 (2007) Vol. 30, No. 2 Inhibitory Effects of Thunberginols A, B, and F on Degranulations and Releases of TNF-a and IL-4 in RBL-2H3 Cells a,b a a a b Qilong WANG, Hisashi MATSUDA, Koudai MATSUHIRA, Seikou NAKAMURA, Dan YUAN, and ,a Masayuki YOSHIKAWA* a Kyoto Pharmaceutical University; Misasagi, Yamashina-ku, Kyoto 607–8412, Japan: and b Shenyang Pharmaceutical University; 103 Wenhua Road, Shenyang, 110016, China. Received October 11, 2006; accepted November 13, 2006; published online November 22, 2006 Thunberginols A, B, and F from the processed leaves of Hydrangea macrophylla var. thunbergii (Hydrangeae Dulcis Folium) substantially inhibited the degranulations by antigen and calcium ionophore A23187, and the re- leases of TNF-a and IL-4 by antigen in RBL-2H3 cells. Phyllodulcin and hydrangenol also showed significant in- hibition for the antigen-induced degranulations, but their effects were weaker than those of thunberginols A, B, and F. Among them, thunberginol B showed the most potent activity. With regard to structural requirements of thunberginols for the activity, the 3,4-double bond was essential for the strong activity and the 6-hydroxyl group and lactone ring enhanced the activity. Thunberginols A, B, and F inhibited increase in intracellular free Ca2؉ levels, which is an essential process for the degranulation and production of cytokines, in RBL-2H3 cells induced by antigen, but not by calcium ionophore A23187. These results suggested that these active compounds inhibited .the degranulation processes both before and after increase in intracellular free Ca2؉ levels Key words thunberginol; degranulation; tumor necrosis factor a (TNF-a); interleukin (IL-4); Hydrangea macrophylla var. -
Synthesis of 8-Desoxythunberginol a and (±)-8-Desoxy- 3,4-Dihydrothunberginol A
Journal of the Chinese Chemical Society, 2003, 50, 313-317 313 Synthesis of 8-Desoxythunberginol A and (±)-8-Desoxy- 3,4-dihydrothunberginol A Aamer Saeed Department of Chemistry, Quaid-i-Azam University, Islamabad 45320, Pakistan A two step synthesis of title isocoumarin isolated from Homalium longifolium and its conversion into cor- responding 3,4-dihydroisocoumarin has been described. 3,4-Dimethoxybenzoyl chloride on condensation with homophthalic acid afforded 3-(3¢,4¢-dimethoxyphenyl)isocoumarin which was demethylated to furnish the 8-desoxythunberginol A, whereas its sequential saponification, reduction and demethylation yielded the (±)-8-desoxy-3,4-dihydrothunberginol A. The synthesized compounds were examined in vitro for antibacte- rial activity. Keywords: Homalium longifolium; Hydrangea macrophylla; Thunberginol A; Isocoumarins; Anti- bacterial. INTRODUCTION mine release from rat peritoneal mast cells induced by com- pound 48/80, calcium ionophore A23187, with IC50 values of In 1995, K. Shaari isolated 3-(3¢,4¢-dihydroxyphen- less than 100 mM. Structure-activity studies have shown that yl)isocoumarin (1a; R=H) from the stem of Homalium isocoumarins such as thunberginol A and B are more potent longifolium Benth., a rain forest tree found in the southern as histamine release inhibitors as compared to the dihydro- part of the Malay Peninsula.1 Earlier in 1992, M. Yoshikawa isocoumarins such as hydrangenol, thunberginol D and E.6 S. had isolated its 8-hydroxy derivative: thunberginol A (1b; Ohta has reported a synthesis of thunberginol A&B.7 R=OH) along with thunberginol B, and 3,4-dihydro- deriva- Condensation of acid chlorides with homopthhalic acid tives: thunberginols C, D, E and G from the Hydrangeae is useful for the preparation of 3-substituted isocoumarin Dulcis Folium (amacha or sweet tea) a natural medicine in- skeleton.8,9 Herein a short and efficient synthesis of 8-deso- digenous to Japan, prepared from the leaves of Hydrangea xythunberginol A achieved by using this method and its con- macrophylla SERINGE var. -
Phyllodulcin, a Natural Sweetener, Regulates Obesity-Related
nutrients Article Phyllodulcin, a Natural Sweetener, Regulates Obesity-Related Metabolic Changes and Fat Browning-Related Genes of Subcutaneous White Adipose Tissue in High-Fat Diet-Induced Obese Mice Eunju Kim 1, Soo-Min Lim 1, Min-Soo Kim 2, Sang-Ho Yoo 2 and Yuri Kim 1,* 1 Department of Nutritional Science and Food Management, Ewha Womans University, Seoul 03760, Korea; [email protected] (E.K.); [email protected] (S.-M.L.) 2 Department of Food Science and Biotechnology, and Carbohydrate Bioproduct Research Center, Sejong University, 209 Neungdong-ro, Gwangjin-gu, Seoul 05006, Korea; [email protected] (M.-S.K.); [email protected] (S.-H.Y.) * Correspondence: [email protected]; Tel.: +82-02-3277-4485 Received: 12 July 2017; Accepted: 18 September 2017; Published: 21 September 2017 Abstract: Phyllodulcin is a natural sweetener found in Hydrangea macrophylla var. thunbergii. This study investigated whether phyllodulcin could improve metabolic abnormalities in high-fat diet (HFD)-induced obese mice. Animals were fed a 60% HFD for 6 weeks to induce obesity, followed by 7 weeks of supplementation with phyllodulcin (20 or 40 mg/kg body weight (b.w.)/day). Stevioside (40 mg/kg b.w./day) was used as a positive control. Phyllodulcin supplementation reduced subcutaneous fat mass, levels of plasma lipids, triglycerides, total cholesterol, and low-density lipoprotein cholesterol and improved the levels of leptin, adiponectin, and fasting blood glucose. In subcutaneous fat tissues, supplementation with stevioside or phyllodulcin significantly decreased mRNA expression of lipogenesis-related genes, including CCAAT/enhancer-binding protein α (C/EBPa), peroxisome proliferator activated receptor γ (PPARg), and sterol regulatory element-binding protein-1C (SREBP-1c) compared to the high-fat group.